E2/E3 and E3/E4 Genotypes of the Apolipoprotein E Are Associated with Higher Risk of Diabetes Mellitus in Patients with Hypertension

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2023 Nov 30

PMID 38034897

Authors

Wendao Han

Nating Xiong

Renkai Zhong

Zhongyi Pan

Affiliations

Soon will be listed here.

Abstract

Objective: Apolipoprotein E (APOE) plays an important role in the lipid metabolism. polymorphisms have been implicated in susceptibility to diabetes mellitus (DM). However, the association between polymorphisms and the risk of DM among the hypertensive patients remains unclear. Our study aimed to evaluate this relationship to provide clues for further developing DM in hypertensive patients.

Methods: The study included 808 hypertensive patients with DM and 1226 hypertensive patients without DM as controls. The 388T>C (rs429358) and 526C>T (rs7412) polymorphisms were genotyped by polymerase chain reaction (PCR) - microarray. Differences in genotypes between subjects and controls were compared. To analyze the relationship between genotypes and DM risk, multiple logistic regression analysis was performed after adjusting for gender, age, smoking history, and drinking history.

Results: The E2/E4, E3/E3 genotype and ε2, ε3 allele frequency had significant difference between DM patients and controls (<0.05). The DM patients with ɛ4 allele had lower level in high-density lipoprotein cholesterol (HDL-C) and higher level in apolipoprotein B (ApoB) than those with ɛ2 allele. The results of logistic regression analysis indicated that the genotype of E2/E3 with adjusted OR=1.350 (95% Cl=1.009-1.806, =0.043) and E3/E4 with adjusted OR=1.325 (95% Cl=1.034-1699, =0.026) may be independent risk factors for DM.

Conclusion: E2/E3 and E3/E4 genotypes may be risk factors for developing diabetes mellitus in hypertensive patients.

References

Santos-Ferreira C, Baptista R, Oliveira-Santos M, Costa R, Moura J, Goncalves L . Apolipoprotein E2 Genotype Is Associated with a 2-Fold Increase in the Incidence of Type 2 Diabetes Mellitus: Results from a Long-Term Observational Study. J Lipids. 2019; 2019:1698610. PMC: 6702854. DOI: 10.1155/2019/1698610. View

Petrie J, Guzik T, Touyz R . Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018; 34(5):575-584. PMC: 5953551. DOI: 10.1016/j.cjca.2017.12.005. View

Srirojnopkun C, Kietrungwilaikul K, Boonsong K, Thongpoonkaew J, Jeenduang N . Association of APOE and CETP TaqIB Polymorphisms with Type 2 Diabetes Mellitus. Arch Med Res. 2019; 49(7):479-485. DOI: 10.1016/j.arcmed.2019.02.005. View

Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z . Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation. 2018; 137(22):2344-2356. DOI: 10.1161/CIRCULATIONAHA.117.032380. View

Malyala R, Rapi L, Nash M, Prasad G . Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients. Can J Kidney Health Dis. 2019; 6:2054358119850536. PMC: 6535897. DOI: 10.1177/2054358119850536. View

Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H . Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. Eur J Endocrinol. 2019; 180(6):353-363. DOI: 10.1530/EJE-19-0117. View

Chen D, Shi J, Li Y, Yang Y, Ren S . Association between ApoE Polymorphism and Type 2 Diabetes: A Meta-Analysis of 59 Studies. Biomed Environ Sci. 2020; 32(11):823-838. DOI: 10.3967/bes2019.104. View

Seripa D, DOnofrio G, Panza F, Cascavilla L, Masullo C, Pilotto A . The genetics of the human APOE polymorphism. Rejuvenation Res. 2011; 14(5):491-500. DOI: 10.1089/rej.2011.1169. View

Liu S, Yuan H, Jiang C, Xu J, Qiu X, Luo J . The blood pressure control and arteriosclerotic cardiovascular risk among Chinese community hypertensive patients. Sci Rep. 2021; 11(1):19066. PMC: 8463712. DOI: 10.1038/s41598-021-98745-8. View

10.

Moreno B, Faria A, Ritter A, Yugar L, Ferreira-Melo S, Amorim R . Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus. J Clin Hypertens (Greenwich). 2018; 20(5):910-917. PMC: 8030801. DOI: 10.1111/jch.13293. View

11.

Domingo-Espin J, Nilsson O, Bernfur K, Del Giudice R, Lagerstedt J . Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(9 Pt B):2822-2834. DOI: 10.1016/j.bbadis.2018.05.014. View

12.

Pitchika A, Markus M, Schipf S, Teumer A, Van der Auwera S, Nauck M . Longitudinal association of Apolipoprotein E polymorphism with lipid profile, type 2 diabetes and metabolic syndrome: Results from a 15 year follow-up study. Diabetes Res Clin Pract. 2022; 185:109778. DOI: 10.1016/j.diabres.2022.109778. View

13.

PICKERING G . The natural history of hypertension. Br Med Bull. 1952; 8(4):305-9. DOI: 10.1093/oxfordjournals.bmb.a074193. View

14.

Kim M, Lim N, Choi S, Park H . Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study. Hypertens Res. 2015; 38(11):783-9. PMC: 4644940. DOI: 10.1038/hr.2015.72. View

15.

Galal A, Abd Elmajeed A, Elbaz R, Wafa A, Elshazli R . Association of Apolipoprotein E gene polymorphism with the risk of T2DM and obesity among Egyptian subjects. Gene. 2020; 769:145223. DOI: 10.1016/j.gene.2020.145223. View

16.

Yin R, Yin L, Li L, Silva-Nash J, Tan J, Pan Z . Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review. J Hum Hypertens. 2021; 36(2):126-134. PMC: 8252986. DOI: 10.1038/s41371-021-00570-z. View

17.

Jia G, Sowers J . Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021; 78(5):1197-1205. PMC: 8516748. DOI: 10.1161/HYPERTENSIONAHA.121.17981. View

18.

Liu L, Shen G, Huang J, Yu Y, Chen C, Huang Y . U-shaped association between low-density lipid cholesterol and diabetes mellitus in patients with hypertension. Lipids Health Dis. 2019; 18(1):163. PMC: 6698332. DOI: 10.1186/s12944-019-1105-5. View

19.

Ariyanti R, Besral B . Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta. J Lipids. 2019; 2019:2517013. PMC: 6515015. DOI: 10.1155/2019/2517013. View

20.

Wang J, Ma J, Liu J, Zeng D, Song C, Cao Z . Prevalence and Risk Factors of Comorbidities among Hypertensive Patients in China. Int J Med Sci. 2017; 14(3):201-212. PMC: 5370282. DOI: 10.7150/ijms.16974. View